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etta et al., 2001), and some activating isoforms of KIRsSummary
and ILTs/LIRs. Activating CTLR receptors include CD94/
NKG2C, CD94/NKG2E, activating isoforms of Ly49, andNKG2D is known to trigger the natural killer (NK) cell
NKG2D. All activating receptors, except 2B4, display alysis of various tumor and virally infected cells. In the
charged lysine or arginine residue in their transmem-NKG2D/ULBP3 complex, the structure of ULBP3 re-
brane region to pair with a negatively charged adaptorsembles the 1 and 2 domains of classical MHC mol-
molecule, such as DAP12, DAP10, CD3, or FcR.ecules without a bound peptide. The lack of 3 and
NKG2D is a member of CTLR superfamily and is dis-2m domains is compensated by replacing two hy-
tantly related to NKG2A, B, C, and E. When expressed ondrophobic patches at the underside of the class I MHC-
NK cells, NKG2D can trigger cytotoxicity against certainlike  sheet floor with a group of hydrophilic and
tumor cells; expression on CD8  T and  T cellscharged residues in ULBP3. NKG2D binds diagonally
provides a costimulatory signal against virally infectedacross the ULBP3helices, creating a complementary
cells (Bauer et al., 1999; Wu et al., 1999; Groh et al.,interface, an asymmetrical subunit orientation, and lo-
2001; Das et al., 2001). Efforts to search for NKG2Dcal conformational adjustments in the receptor. The
ligands have led to the identification of MICA and MICBinterface is stabilized primarily by hydrogen bonds and
in humans and Rae-1 and H60 in mice (Bauer et al.,hydrophobic interactions. Unlike the KIR receptors
1999; Cerwenka et al., 2000; Diefenbach et al., 2000).that recognize a conserved HLA region by a lock-and-
MICA and MICB display 1, 2, and 3 domains similarkey mechanism, NKG2D recognizes diverse ligands
to those found in class I MHC heavy chains, but do notby an induced-fit mechanism.
associate with peptides or 2-microglobulin (Li et al.,
1999). Rae-1 and H60 are also class I-like molecules,Introduction
but contain only the 1 and 2 domains. More recently,
a group of human cytomegalovirus glycoprotein UL16
The activity of natural killer (NK) and myeloid cells de- binding proteins, named ULBPs, have been identified as
pends on the balance of a number of activating and additional ligands to human NKG2D. Like Rae-1, ULBPs
inhibitory receptors (Moretta et al., 2001; Long, 1999). contain only 1 and 2 domains similar to those of class
In the past few years, much effort has been focused on I MHC, do not bind peptides, and are GPI-anchored
characterizing the structure and function of the inhibitory (Cosman et al., 2001). The sequence identities among
NK cell receptors specific for MHC class I molecules. MICs and ULBPs are about 25%, making NKG2D a
These receptors inhibit NK cell-mediated lysis of target unique activating receptor with the ability to bind diverse
cells expressing class I MHC molecules, while allowing MHC class I-like ligands. The structural basis of such
lysis of class I-negative cells (Ljunggren and Karre, 1990). broad specificity of NKG2D is yet unknown. Recently,
Structurally, the inhibitory receptors belong to either the the crystal structures of NKG2D and its complex with
immunoglobulin superfamily (IgSF) or the C-type lectin- MICA revealed that the receptor adopts a CD94-like
like receptor (CTLR) superfamily. IgSF inhibitory receptors structure, and its recognition of MICA shares similarity
include the human killer cell Ig-like receptors (KIR), which with, but is distinctly different from, the recognition of
recognize the 1 and 2 domains of human leukocyte classical class I MHC molecules by T cell receptors
antigens (HLA)-A, -B, and -C and the Ig-like transcripts (TCR) (Wolan et al., 2001; Li et al., 2001). Here, we report
(ILTs, also named as leukocyte Ig-like receptors or LIRs) the 2.6 A˚ resolution structure of the extracellular domain
of human NKG2D complexed with ULBP3. Comparison
of this complex with previous NKG2D structures reveals4 Correspondence: psun@nih.gov
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Table 1. Data Collection, Phasing, and Refinement Statistics
Data Collection SeMet (remote) SeMet (peak) SeMet (edge)
Wavelength (A˚) 0.9639 0.9792 0.9795
Resolution limit (A˚) 2.7 2.6 2.7
Unique reflections 24349 (2404)a 26678 (2683) 24396 (2412)
Redundancy 4.4 (4.3) 5.4 (5.2) 7.1 (7.0)
Completeness (%) 99.9 (99.9) 99.7 (99.9) 99.9 (99.9)
Rsym (%)b 9.0 (43.5) 8.3 (40.0) 8.2 (37.5)
I/(I)	 19.1 (3.5) 22.6 (3.9) 29.5 (5.7)
Phasing (41–2.9 A˚)
Mean figure of merit 0.59
RCullisc 0.76 0.68 0.62
Phasing powerd 1.32 1.73 1.92
Refinement
Resolution (A˚) 41–2.6
No. reflections 14728
No. protein atoms 3406
No. solvent atoms 122
Rcryst (%) 22.0 (38.6)
Rfree (%)e 26.8 (49.0)
Mean B-factor (A˚2) 39
Wilson B-factor (A˚2) 55
Rmsd bond lengths (A˚) 0.009
Rmsd bond angles (
) 1.89
Percentage of residues for the: most favored region, 78.7%; additional allowed region, 19.1%; generously allowed region, 2.2%; and disallowed
region, 0.0% of Ramachandran plot.
a Values for highest resolution shells: remote, 2.8–2.7; peak, 2.7–2.6; and edge, 2.8–2.7 A˚ are given in parentheses.
b Rsym  100  |Ih  Ih	|/Ih, where Ih	 is the mean intensity of multiple measurements of symmetry equivalent reflections.
c RCullis  rms(E)/rms(F), where E is the phase-integrated lack of closure and F is the dispersive or anomalous difference.
d Phasing power  rms(FH)/rms(E), where FH is the calculated heavy-atom structure factor.
e Rfree was calculated using test set of 5%.
the molecular basis for the broad specificity of NKG2D. half of the 1 helix and the N-terminal half of the 3
helix of ULBP3 (Figure 1B). Both subunits of NKG2DThe crystal structure of ULBP3 provides an image of a
class I-like molecule that lacks the 3 domain and is bind ULBP3 with identical receptor loops. However, the
interaction between a homodimeric NKG2D and theGPI-anchored to the membrane.
asymmetrical ULBP3 results in an asymmetrical recep-
tor subunit orientation that contrasts with the perfectResults and Discussion
2-fold symmetry observed in the ligand-free murine re-
ceptor.Overall Structure of the Complex
The structure of a human NKG2D receptor in complex
with its ligand, ULBP3, has been determined by a combi- The ULBP3 Structure
As predicted from its sequence, the ULBP fold consistsnation of molecular replacement and multiwavelength
anomalous dispersion (MAD) methods and refined to of a set of 1/2-like domains of MHC molecules, with
two long helices situated atop an eight-stranded anti-2.6 A˚ resolution (Table 1). The refined (2Fo-Fc) electron
density is continuous throughout the complex, except parallel  sheet (Figures 1 and 2). The same fold is also
observed in the structure of MICA, with the exceptionfor one surface loop of ULBP3 (residues 90–97) at the
C-terminal end of the 1 helix, and is away from the that ULBP3 lacks the corresponding 3 domain of a
class I MHC heavy chain (Figure 3) (Li et al., 1999). Areceptor interface. The refined R factors are 22.0% and
26.8% for Rcryst and Rfree, respectively. Each crystallo- structural comparison resulted in root-mean-square
(rms) differences of 2.2 A˚ for 138 C atoms betweengraphic asymmetric unit contains one NKG2D dimer and
one ULBP3 molecule. ULBP3 and MICA and 2.5 A˚ for 131 C atoms between
ULBP3 and HLA-Cw3. The conformation of the eight-The overall shape of the NKG2D/ULBP3 complex re-
sembles a crab preying on a seashell (Figure 1A). The crab stranded sheet agrees quite well among ULBP3, MICA,
and HLA-Cw3. The differences exist primarily in the loopshaped receptor uses its claw shaped strands and loops
at the end opposite to both the N and C termini to grab and helical regions. All class I and II MHC molecules
present peptides. An obvious question here is whetheron the ridge-shaped helical surface of ULBP3. This mode
of complex formation is also observed in the NKG2D/MICA ULBP retains the peptide binding capability. No peptide
has been found associating with known MHC-like pro-complex (Figure 3A). The relative orientation between
NKG2D and ULBP3 is similar to that between KIR and teins, such as the neonatal Fc receptor (FcRn) (Burmeis-
ter et al., 1994), hereditary haemochromatosis proteinHLA and that between TCR and its MHC ligands. The long
axis of the receptor fits diagonally across the helical axes HFE (Bennett et al., 2000), and MICA (Figure 3D). Like-
wise, no visible electron density could be attributed toof ULBP3. The receptor footprint covers the C-terminal
Crystal Structure of NKG2D in Complex with ULBP3
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Figure 1. Ribbon Drawing of the NKG2D-ULBP3 Complex
(A) Front view. Subunits A and B of the NKG2D homodimer are shown in yellow and green, respectively. ULBP3 is colored red. All secondary
structure elements on the NKG2D monomer and major ones on ULBP3 are marked in accordance with the sequence alignment in Figure 2.
(B) Top view of the NKG2D and ULBP3 complex. The color scheme is the same as in (A). ULBP3 residues in contact with the receptor are
shown in white.
(C) The structure of the KIR2DL2 (green) and HLA-Cw3 (yellow) complex. The view is the same as in (B). The peptide is shown in magenta.
This figure and all subsequent ribbon drawings are prepared using the programs MOLSCRIPT (Kraulis, 1991) and RASTER3D (Merritt and
Bacon, 1997).
peptides near the corresponding peptide binding region In contrast, the corresponding residues in ULBP3 (and
those in the sequences of Rae-1 and H60) are mostlyof ULBP3. The spacing between the  helices of ULBP3
ranges from 8 to 14 A˚, the narrowest among all MHC hydrophilic and charged residues that exist favorably
when exposed to the solvent (Figure 3C). MICA alsohomologs (Figure 3D). In comparison, the separation
between the opposing 1 and 3 helices of HLA-Cw3 lacks the hydrophobic residues in the corresponding
2m attachment site of MHC and, thereby, exists stablyis 15–20 A˚. The narrow groove of ULBP3 is filled with
13 hydrophobic side chains from the opposing helices without the 2m subunit. This predicts that stable 1/2
domains can only exist in class I MHC molecules provid-(Figure 3B). In addition, a salt bridge, conserved in all
three ULBP sequences, is formed between Asp 87 of ing the hydrophobic residues in the two hydrophobic
patches are mutated to hydrophilic or charged residues.the 1 helix and Lys 151 of the 2 helix, which further
stabilizes the closed groove conformation.
The NKG2D Structure
As a member of CTLR superfamily, NKG2D is distantlyClass I MHCs but Not ULBP3 Require 3 and 2m
Domains for Their Stabilities related to NKG2A, B, and C, sharing less than 30% in
sequence identity. Unlike other NKG2 receptors that pairA distinct feature of the ULBP structure is that it lacks
the homologous 3 and 2m domains of class I MHC. with CD94, NKG2D functions as a homodimeric receptor.
The structure of NKG2D was solved by molecular re-This appears to contradict the belief that the class I
MHC fold is not stable without the 3 and 2m domains. placement using a murine NKG2D as the initial model
(Wolan et al., 2001). The two subunits of the NKG2D haveWhen the underside of the eight-stranded  sheet is
compared between ULBP3 and MHC structures, this nearly identical structures with a 0.6 A˚ rms deviation
between 119 superimposed C atoms (Figure 4A). Eachregion is considerably more hydrophobic in class I MHC
molecules than in ULBP3. In fact, there are two hy- subunit can also be readily superimposed onto those
of murine NKG2D, resulting in rms deviations of 0.7–0.9drophobic patches located at the underside of MHC
1/2 domains that interact with a set of hydrophobic A˚ with the free and MICA-complexed receptor (Figure
4B). Similar to the MICA-bound receptor, the ULBP3-residues from the3 and 2m domains (Figure 3C). Most
of these hydrophobic residues are conserved among bound NKG2D displays a 5
 rotation between the mono-
mers, creating an asymmetric arrangement of the receptorclass I MHC sequences. Without the 3 and 2m do-
mains, these hydrophobic patches would be exposed dimer. Only two loop regions, residues 162–164 and 183–
186, deviate more than 4 A˚ among the three forms ofto the solvent, creating stability and solubility problems.
Immunity
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Figure 2. The Amino Acid Sequence of ULBPs and NKG2D
(A) Sequence alignment among the corresponding 1 and 2 regions of ULBP1, 2, and 3, MICA/B, HLA-A2, HLA-E, and HLA-Cw3. Residues
identical to the ULBP3 sequence are represented by (-). Gaps are indicated with (.). The numbering is consistent with the mature sequence
of ULBP3. The secondary structure elements of ULBP3 illustrated as arrows for  strands and cylinders for  helices are 1 (9–21), 2 (29–37),
3 (39–46), 4 (49–56), 5 (98–110), 6 (116–123), 7 (126–132), 8 (136–142), 310 helix (60–64), 1 (65–87), 2 (145–155), and 3 (156–183).
The ULBP3 residues interacting with NKG2D are highlighted in red and underlined. The MICA residues in contact with NKG2D, as reported
in the NKG2D/MICA complex crystal structure, are boxed in blue.
(B) Regions of the NKG2D sequence, including the ULBP3 interface, are shown for both subunits with the secondary structure illustrated.
Amino acids of the A and B subunits that are in contact with ULBP3 are highlighted in red and underlined, and residues that interact with
MICA are boxed in blue. L1, L2, and 6 are involved in the binding of ULBP3.
NKG2D structures. The conformational difference in the in the dimer orientation is found when the structure of
NKG2D is compared with CD94. The NKG2D dimer inter-first loop, residues 162–164, is most likely caused by
crystal packing forces, since it is located at a crystal face is formed by the juxtaposition of the 1 strand from
each monomer and by the abutting of the short 310 contact region. The second loop, residues 183–186 (L2),
contacts ULBP3, and its conformation may reflect the helices, similar to CD94 homodimer. In addition, interac-
tions between the N termini of NKG2D (Tyr 95, Cys 96,influence of the ligand. Superpositions of NKG2D with
CD94 and Ly49A resulted in rms deviations of 1.4 A˚ and and Pro 98) further extend the receptor dimer interface
to 1850 A˚2, compared to 1200 A˚2 observed in the struc-1.7 A˚, respectively, for 97 pairs of C atoms (Figure 4C).
The second canonical helix, common to Ly49A and other ture of CD94 (Boyington et al., 1999).
C-type lectins, is only a one-turn 310 helix in the structure
of NKG2D and is further deformed in CD94. Like CD94, The Interface between NKG2D and ULBP3
The two NKG2D subunits form a concave surface inNKG2D also lacks the appropriate Ca2 ligands in its
corresponding “Ca2 binding loops” and thus is pre- which the convex shaped ULBP3 interacts with both
subunits of the receptor. The interface shape comple-sumed to be a non-Ca2 binding CTLR. A 25
 rotation
Crystal Structure of NKG2D in Complex with ULBP3
1043
Figure 3. Structural Comparison of ULBP3 with Other Class I MHC-Related Molecules
(A) Structural overlay between the NKG2D/ULBP3 (red) and NKG2D/MICA (cyan) complexes. The complexes are superimposed at the respective
NKG2D. The 3 domain of MICA is omitted for clarity. The coordinates for the NKG2D/MICA complex are taken from the Protein Data Bank
entry 1hyr.
(B) Hydrophobic residues that fill the inside of the groove between the helices.
(C) Surface representation of the interface between the 1/2 (cyan worm) domains and the 3 and 2m domains of MHC class I. Positively
charged, negatively charged, polar, and hydrophobic residues are colored blue, red, yellow, and white, respectively. Areas of 1/2 domains
contacting 3 and 2m are outlined in white and magenta, respectively. For comparison, the corresponding residues of ULBP3 (green worm)
are also shown with the same color scheme. This figure and Figure 5C were generated using the program GRASP (Nicholls et al., 1991).
(D) Structural comparison of the 1 and 2 domains of class I MHC with its homologs. The top panel shows the spacing of the helices in the
1 and 2 domains. The bottom panel shows the space-filling model of the putative peptide binding groove (indicated by the arrows). The
groove is partially closed in the structures of FcRn, HFE, and MICA and completely disappears in ULBP3. The Protein Data Bank entries are
1efx, 1exu, 1de4, and 1b3j for HLA-Cw3, FcRn, HFE, and MICA, respectively.
mentarity value Sc is 0.65 between the receptor and total interface area. In all, six receptor segments, three
similar segments from each subunit, interact with theULBP3 (Lawrence and Colman, 1993), similar to that
between antibodies and antigens (Ysern et al., 1998), ligand (Figure 2B). They are loop L1, residues 150–152;
loop L2, residues 180–186 (also referred as the Ca2greater than those between KIR and HLA or between
TCR and MHC (Sc  0.5–0.6) (Boyington et al., 2000a), binding region in a classical C-type lectin); and strand
6. The receptor-ligand interface is stabilized primarilybut smaller than the value of 0.72 between NKG2D and
MICA (Li et al., 2001). This indicates a good surface by a network of hydrogen bonds and hydrophobic inter-
actions (Figure 5; Table 2). There are ten hydrogen bondscomplementarity at the receptor-ligand interface. The
total buried interface is 1930 A˚2 (8.2% and 10.7% of the throughout the interface area; subunit A contributes six
and subunit B contributes four (Figure 5A; Table 2). Eachrespective NKG2D and ULBP3 surfaces), slightly smaller
than the 2180 A˚2 buried between NKG2D and MICA (Li NKG2D subunit forms a hydrophobic patch with ULBP3,
using the same receptor residues (Tyr 152, Ile 182, Metet al., 2001), but larger than the 1560 A˚2 interface be-
tween KIR and HLA (Boyington et al., 2000a) or the 184 and Tyr 199), but different ligand residues (Figure
5B). The hydrophobic patch within subunit A contacts1700–1800 A˚2 between TCR and MHC (Garboczi et al.,
1996; Garcia et al., 1996; Reinherz et al., 1999). Each Met 164 and Arg 168 (the aliphatic region) of ULBP3,
whereas the patch within subunit B interacts with Glnreceptor subunit contributes approximately half of the
Immunity
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Figure 4. Structural Comparisons between the NKG2 Family of C-Type Lectin Receptors
Superpositions are shown between the structures of (A) subunit A (yellow) and B (green) of the ULBP-bound NKG2D; (B) subunit B (green) of
the current NKG2D and ligand-free receptor (magenta); and (C) the subunit B (green) of the current NKG2D and CD94 monomer (red). The
coordinates for the free NKG2D and CD94 receptors are from the Protein Data Bank entries 1hq8 and 1b6e, respectively. (D) Stereo view of
a structrual comparison between the ULBP3 binding loops in the A (white) and B (cyan) subunits of NKG2D. Tyr 152 in loop L1 displays
different side chain rotamer conformation in A and B subunits. L2 loops in the two subunits display the largest conformational changes.
Strand 6 has the same conformation in both subunits. (E) Structural comparison among the known NKG2D structures shown as the
displacement in the C atoms. Curves 1, 2, 3, and 4 are the calculated differences in C positions between the current NKG2D A and B
subunits; the current subunit A and that from the MICA complex; the current subunit B and the ligand-free NKG2D structure; and the current
subunit A and the ligand-free NKG2D structure, respectively. The two MICA-bound NKG2D subunits display a similar L2 loop conformation
that is different from the ligand-free NKG2D. Curves 1, 2, and 3 are shifted along the vertical axis for clarity. Shaded regions indicate the
ULBP binding loops, L1, L2, and strand 6. Large structural displacement indicates main chain conformational changes.
79, Leu 83, Ala 86, and Arg 82 (the aliphatic region) of ligand systems. Many cytokine signalings are thought
to involve induced-fit mechanisms, as observed in theULBP3. Two salt bridges are formed at the interface,
one between Lys 197 of subunit A and Asp 169 of ULBP3 structures of hematopoietic cytokines and their receptor
complexes and as demonstrated by mutational studiesand the other between Lys 150 of subunit B and Glu 76
of the ULBP. There are, however, unbalanced charges on the growth hormone receptor (de Vos et al., 1992;
Atwell et al., 1997; Livnah et al., 1996). Certain T cellat the interface. For example, Lys 150 of NKG2D subunit
A is in close contact (4.2 A˚) with Arg 80 of the ULBP receptor and class I MHC complexes (Garcia et al.,
1998), IgE-Fc and FcRI complexes (Garman et al.,with no counter charges nearby, creating an unfavorable
electrostatic interaction. The lack of an overall charge 2000), and antigen-antibody complexes are also exam-
ples of induced-fit recognitions. In contrast, the KIR/complementarity implies that charge-charge interac-
tions play a secondary role in the receptor-ligand recog- HLA complex, IgG-Fc/FcRIII receptor complex, and ad-
hesion CD2/CD58 complex are examples of the lock-nition (Figure 5C).
and-key type of recognition (Boyington et al., 2000a;
Radaev et al., 2001; Wang et al., 1999).Conformational Plasticity
in NKG2D/ULBP3 Recognition The NKG2D/ULBP3 complex displays characteristic
features of an induced-fit recognition. First, binding toConformational plasticity or induced-fit binding refers to
a situation where a receptor undergoes ligand-specific ULBP resulted in an asymmetric orientation of the homo-
dimeric NKG2D subunits. A similar adjustment in theconformational adjustments upon complex formation.
This is opposed to lock-and-key recognition, where no receptor subunits was also observed in the NKG2D/
MICA complex structure (Li et al., 2001). In addition,conformational adjustment takes place upon complex
formation. Both induced-fit and lock-and-key modes of local conformational changes are also observed in the
three NKG2D elements that contact the ULBP. Specifi-recognition have been observed in various receptor-
Crystal Structure of NKG2D in Complex with ULBP3
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Figure 5. Interface Residues between NKG2D and ULBP3
(A) Residues involved in hydrogen bonds (black dotted lines) and salt bridges (red dotted lines). NKG2D is colored in yellow and green for A
and B subunits, respectively. ULBP3 is colored in red. Residues are colored according to their chain color. The view is similar to the front
view of Figure 1A.
(B) Residues involved in hydrophobic interface patches. The color scheme is the same as in (A). Tyr 152, Ile 182, Met 184, and Tyr 199 from
NKG2D subunit A form a hydrophobic patch with Met 164 and Arg 168 from the 3 helix of ULBP3. The same residues from subunit B form
a hydrophobic patch with Gln 79, Arg 82, Leu 83, and Ala 86 from the 1 helix of ULBP3.
(C) Surface representation of the NKG2D/ULBP3 interface colored according to electrostatic potential distribution, with positive charges in
blue and negative charges in red. Patches of ULBP3 in contact with A and B subunits of NKG2D are outlined in yellow and green, respectively.
(D) Conformational plasticity involved in the recognition of ULBP and MICA by NKG2D. Side chains in the NKG2D/ULBP3 complex and the
NKG2D/MICA complex are shown in red and cyan, respectively. Only those hydrogen bonds and salt bridges that are different between the
two complexes are presented as red and cyan dotted lines for NKG2D/ULBP3 and NKG2D/MICA, respectively. In both the NKG2D/ULBP3
and the NKG2D/MICA structures, Tyr 199 of NKG2D subunit A forms a hydrogen bond with Asp 169 (Asp 163 in MICA). However, in the
complex with ULBP3, Asp 169 (ULBP3) also forms a salt bridge with Lys 197 of the NKG2D subunit, whereas the same Lys 197 from the
MICA-bound receptor makes a salt bridge with Asp 65 (MICA). In the ULBP3 complex, Ser 195 of NKG2D subunit A forms a hydrogen bond
with Glu 72, whereas the same residue in the MICA complex is bound to Arg 64. In the MICA complex, Lys 150 of NKG2D subunit A forms a
hydrogen bond with the carbonyl oxygen of Ala 150, whereas in the ULBP3 complex, the same lysine makes no hydrogen bonds and is in
close contact with Arg 80 of ULBP3. In both the ULBP3 and MICA complexes, Tyr 152 of NKG2D subunit B makes hydrogen bonds with Arg
82 (Arg 74 in MICA). However, in the MICA complex, Arg 74 forms a salt bridge with Glu 201 of NKG2D, whereas in the ULBP3 complex, Glu
201 is located 4.5 A˚ apart from Arg 82.
cally, the L2 loop from the A subunit displays the same receptor residues were recruited from each subunit to
match the asymmetric ULBP3 surfaces. Although bothconformation as in the ligand-free receptor (Figure 4E,
curve 4), whereas the same loop in the B subunit adopts subunits of NKG2D employ loops L1 and L2 and 6
strand to bind ULBP3, about half of the interface resi-an alternative conformation that is also represented in
the structure of the MICA-bound NKG2D (Figures 4D dues vary between the subunits as a result of interacting
with different ULBP3 residues (Figure 2B; Table 2). Theand 4E, curves 1, 3, and 4). Residues of the L1 loop and
6 strand, such as Lys 197 and Tyr 152, adopt unique ability of NKG2D to recruit different residues to match
similar but distinct ligand surfaces is best exemplified byside chain conformations in each subunit, resulting in
different hydrogen bond and salt bridge formations comparing the NKG2D/ULBP3 structure with NKG2D/
MICA structure. MICs and ULBPs have similar structuresupon complex formation (Figure 4D). Second, different
Immunity
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Table 2. Interface Contacts between NKG2D and ULBP3
NKG2D Chain ID ULBP3 Distance (A˚)
Hydrogen bonds and salt bridges
Thr 180 O1 A Lys 69 N 2.6
Glu 183 O A Lys 171 N 2.7
Met 184 O A Lys 171 N 2.9
Ser 195 O A Glu 72 O2 3.0
Lys 197 N A Asp 169 O2 2.7
Tyr 199 OH A Asp 169 O2 2.4
Ile 200 O A Arg 168 NH1 2.8
Lys 150 N B Glu 76 O2 2.7
Lys 150 N B Glu 76 O1 3.4
Ser 151 O B Gln 79 O1 2.7
Glu 183 O B His 21 N2 3.4
Tyr 152 OH B Arg 82 NH2 3.1
Met 184 O B His 21 N2 3.4
Hydrophobic contactsa
Tyr 152 A Met 164
Ile 182 A Arg 168
Met 184 A Arg 168
Tyr 199 A Met 164, Arg 168
Lys 150 B Glu 76
Tyr 152 B Gln 79, Leu 83
Ile 182 B Ala 86, Asp 87
Met 184 B His 21, Arg 82, Ala 86
Gln 185 B Pro 23
Ala 193 B Leu 83
Tyr 199 B Leu 83
a The list of contacts  4.0 A˚.
but share only 25% sequence identity. Despite an overall served than the overall sequence identity among the
ULBPs. It is predicted that NKG2D recognizes ULBP1similarity in the receptor docking between MICA and
ULBP3, the detailed receptor-ligand interactions are and ULBP2 through induced-fit mechanisms in a similar
orientation as that of ULBP3.quite different. For example, Ser 195 of NKG2D forms
a hydrogen bond with Glu 72 of ULBP3, but the same
Ser interacts with Arg 64 of MICA. Among the 12 ULBP3 Comparison of the Plastic Recognition
between NKG2D/ULBP3 and TCR/HLAresidues that contact NKG2D, only two, Arg 82 and Asp
169, are conserved in MICA (Figures 2A and 5D). How- The observed plastic recognition in the NKG2D/ULBP3
complex is not unprecedented. A similar situation hasever, they do not mediate the same interface contacts.
While Asp 169 of ULBP3 forms a salt bridge with Lys been observed in the structures of  T cell receptor and
class I MHC complexes. T cell receptors are, in general,197 of NKG2D, the equivalent Asp in MICA is too distant
(4.7 A˚) from Lys 197 to form a salt bridge. Instead, Lys restricted to particular MHC and peptide complexes.
There are often multiple clones of T lymphocytes that197 forms a salt bridge with Asp 65 of MICA, which has
no counterpart in ULBP3 (Figure 5D). It appears that the recognize the same MHC-peptide complex. For exam-
ple, both the human A6 TCR and B7 TCR, which containinterface is less preserved than the overall sequence
conservation between MICA and ULBP3. It should be different V segments, recognize the same HLA-A2 pre-
senting the HTLV-1 Tax peptide. The crystal structuresnoted, however, that the interface residues of ULBP3
and MICA are derived from the corresponding second- of both A6 TCR and B7 TCR in complex with the same
HLA-peptide ligand have been determined (Garboczi etary structure elements; i.e., they share common hot
spots for the receptor binding (Figures 1B and 2A). Simi- al., 1996; Ding et al., 1998). Comparison of the two TCR/
HLA complexes showed that both TCRs bound to HLA-larly, on the receptor side, overlapping but distinct resi-
dues of NKG2D are used to bind both ULBP3 and MICA A2 in similar location and orientations. The detailed inter-
face, however, is quite different between the two TCR/(Figure 2B). This receptor conformational plasticity in
both the domain and the side chain orientations enables HLA complexes. Among the 17 HLA contact residues
of B7 TCR, 16 are different from those observed in thethe receptor to adapt various ligand surfaces while pre-
serving an overall receptor-ligand docking orientation. A6 TCR/HLA-A2 complex. Moreover, the two receptors
contact a set of overlapping but distinct HLA-A2 resi-To date, there are three known ULBP molecules, shar-
ing 55%–60% sequence identity (Cosman et al., 2001). dues. The differences in the interface amino acids were
accommodated by minor conformational changes in theAll have been shown to be ligands of NKG2D. However,
only 1 of the 12 ULBP3 interface residues, Asp 169, CDR loops of the TCR V and V chains, such that
both receptors recognize the same HLA-A2 in a similarwhich forms a salt bridge with Lys 197 of NKG2D, is
conserved among the three ULBP sequences (Figure orientation. Conformational plasticity was also observed
in the murine 2C TCR and H-2kd complex (Garcia et al.,2A). Again, the interface residues appear to be less con-
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1998). The observation of plastic interfaces in both the Peruzzi et al., 1996), suggesting that KIR/HLA recogni-
tion is sensitive to interface mutations or less tolerantNKG2D/ULBP3 and NKG2D/MICA complexes suggests
that NKG2D uses an induced-fit rather than lock-and- to sequence changes. A lock-and-key recognition would
ensure less tolerance to mutations, thus preventing thekey mechanism to achieve its specificity for multiple
ligands. It is possible that induced-fit occurs as a general inhibitory KIR receptors from recognizing altered self.
It is tempting to speculate that the receptor-ligandmechanism for receptors to recognize diverse ligands.
binding affinities also reflect their functional needs. For
example, KIR/HLA interactions were characterized withA Model for CD94/NKG2A Recognition of HLA-E
a KD of 10–30 M (Boyington et al., 2000a; Maenaka etIt is anticipated that the overall docking between CD94/
al., 1999), whereas the KD for NKG2D/MICA binding wasNKG2 receptors and HLA-E resembles that between
about 1 M (Li et al., 2001). It is conceivable that theNKG2D and ULBP3, owing to the structural similarities
higher ligand affinity of NKG2D permits recognition ofin both the receptors and the ligands (O’Callaghan et
variant ligand forms and provides the basis for muta-al., 1998; Boyington et al., 1999). A model for a complex
tional tolerance. Alternatively, it is advantageous for thebetween CD94/NKG2 and HLA-E can be generated in
self-recognizing inhibitory receptors to have a lower li-which the peptide of HLA-E, specifically the Arg at the
gand binding affinity to be less tolerant to mutations.P5 position, forms a hydrogen bond with a Ser residue
In conclusion, the activating receptor NKG2D recog-on the respective L1 loop of NKG2A.
nizes nonconserved regions of both ULBP3 and MICA
using an induced-fit mechanism. First, NKG2D recog-Implications for the Activating and Inhibitory NK
nizes multiple ligands of diverse amino acid sequences,Receptor Functions
as evident from the lack of sequence conservation atIn contrast to the adapted immune receptors, such as
the interface. Second, the receptor uses topologicallyantibodies and TCR, which rely on gene recombination
similar but distinct sets of interface residues to counterand somatic mutations to give rise diverse ligand speci-
the structural variation in ULBP3 and MICA. Finally, iden-ficities, innate immune receptors are germline coded
tical residues on the two NKG2D subunits mediate differ-and lack the flexibility to adapt multiple ligands at gene
ent interactions with ULBP3, leading to conformationallevel. Two distinct mechanisms appear to have evolved
adjustment of the interface residues. Although the struc-for the activating and inhibitory NK receptors to over-
ture of the NKG2D/ULBP3 complex offers considerablecome their ligand diversities. NKG2D, an example of the
insight into the function of this triggering receptor, manyactivating receptors, uses induced-fit mechanisms to
questions regarding the receptor-ligand recognition re-recognize ligands with less than 20% sequence conser-
main to be answered. For example, it is still not clearvation. Functionally, the activating receptor NKG2D rec-
what structural themes are shared among the diverseognizes tumor or viral infections by alerting molecules
ligands to qualify them as the ligands of NKG2D. Namely,such as MICs and ULBPs. The polymorphism and se-
what are the criteria for receptor-ligand recognition?quence diversity observed in MIC and ULBP presumably
Will recognition be more tolerant of interface mutations,reflect the diversity of pathogens. Through induced-fit
as suggested from the structural results? Finally, doesmechanisms, the receptor acquires the ability to bind
the receptor aggregate upon ligand binding, and, if so,multiple ligands with little sequence conservation. For
what is the synaptic structure of NKG2D? Space groupexample, the human cytomegalovirus-encoded protein
symmetry precludes the formation of an oligomeric stateUL16 binds to ULBP1, ULBP2, and MICB, but not to
in the current crystal that would be consistent with whatULBP3 or MICA (Cosman et al., 2001). One possible
might form in the synapse. This, however, does not rulefunction of UL16 is to block immune recognition of the
out the possibility that NKG2D forms large molecularvirus-infected cells by binding and interfering with the
aggregates in the presence of coreceptors and adhesionligand recognition of NKG2D. The ability to recognize
molecules.multiple ligands or highly polymorphic ligands provides
a means for NKG2D to circumvent the viral blockade of
Experimental Proceduresa particular NKG2D/ligand interaction. In contrast, the
structures of inhibitory KIR/HLA complexes showed lit-
Protein Expression, Purification, and Crystallizationtle or no conformational changes upon ligand recogni-
The extracellular parts of human NKG2D receptor (residues 75–216)
tion (Boyington et al., 2000a; Fan et al., 2001), indicating and ULBP3 (residues 1–200 with a His6 tag) were both expressed
a lock-and-key or rigid body recognition between the in Escherichia coli as inclusion bodies and then reconstituted in
vitro. In brief, cells containing NKG2D- or ULBP3-expressing plas-KIR and HLA. Among the multiple class I MHC ligands
mid were grown at 37
C in 10 l of LB (Luria-Bertani) broth using aof KIR, the interface residues, contrary to those of the
Newbrunswick Bioflo 3000 Bioreactor vessel and were induced withNKG2D ligands, are over 90% conserved. Functionally,
0.5 mM IPTG at an approximate OD596 of 1.7 for 4 hr. The inclusionthe inhibitory receptors recognize primarily self-mole-
bodies were isolated by repeated washes with 2 M urea solution
cules on normal cells. Alteration of self constitutes a and then redissolved in 6 N guanidine hydrochloride prior to refold-
necessary and sufficient signal of danger and leads to ing. The refolding was initiated by a quick dilution of dissolved
inclusion bodies into a refolding buffer consisting of 0.5 M L-argi-the release of inhibition. Since a self entity rarely
nine, 2.5 mM cystamine (or oxidized glutathione), 5 mM cysteaminechanges, the inhibitory receptors, therefore, can and
(or reduced glutathione), 10 g/ml AEBSF (4-2[-aminoethyl]-ben-must be very specific for self-molecules and less toler-
zenesulfonyl fluoride hydrochloride), and 100 mM Tris (pH 8.0) andant to mutations. Single amino acid mutations in KIR
then dialyzed thoroughly against water (Boyington et al., 2000b).
receptors have been known to result in nearly complete The renaturated NKG2D was concentrated on a Source Q column
loss of ligand binding and loss of protection against (Amersham Pharmacia Biotech), and the renatured ULBP3 was con-
centrated on a Ni-NTA affinity column (Qiagen). Both proteins werekilling (Boyington et al., 2000a; Zappacosta et al., 1997;
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further purified on a Superdex 200 size-exclusion column (Amer- Bennett, M.J., Lebron, J.A., and Bjorkman, P.J. (2000). Crystal struc-
ture of the hereditary haemochromatosis protein HFE complexedsham Pharmacia Biotech). The refolded products were analyzed by
both N-terminal amino acid sequencing and electrospray ionization with transferrin receptor. Nature 403, 46–53.
mass spectrometry (ESI-MS). The selenomethionine (SeMet) deriva- Boyington, J.C., Riaz, A.N., Patamawenu, A., Coligan, J.E., Brooks,
tive of ULBP3 was prepared using a growth condition in which the A.G., and Sun, P.D. (1999). Structure of CD94 reveals a novel C-type
bacterial methionine biosynthetic pathway was inhibited (Van Duyne lectin fold: implications for the NK cell-associated CD94/NKG2 re-
et al., 1993). In brief, 40 mls of bacteria inoculum containing the ceptors. Immunity 10, 75–82.
ULBP expression plasmid were grown at 37
C in LB broth overnight.
Boyington, J.C., Motyka, S.A., Schuck, P., Brooks, A.G., and Sun,
The LB broth in the overnight inoculum was replaced with M9 me-
P.D. (2000a). Crystal structure of an NK cell immunoglobulin-like
dium supplemented with 0.4% glucose, 0.1 mM CaCl2, and 3 mM receptor in complex with its class I MHC ligand. Nature 405, 537–543.
MgSO4 and added to four 1 l shaker flasks at 37
C. The bacterial
Boyington, J.C., Raiz, A.N., Brooks, A.G., Patamawenu, A., and Sun,cell culture was induced at an OD596 of 0.6 with 0.5 mM IPTG for
P.D. (2000b). Reconstitution of bacterial expressed human CD94:12 hr together with added (50 mg/l each) amino acids Leu, Ile, Val
the importance of the stem region for dimer formation. Protein Expr.and (100 mg/l each) Thr, Lys, Phe, and SeMet. The refolding of the
Purif. 18, 235–241.SeMet-modified ULBP was the same as for the native protein. The
presence of nine SeMet residues was confirmed by ESI-MS. Brunger, A.T., Adams, P.D., Clore, G.M., Delano, W.L., Gros, P.,
The complex of NKG2D and ULBP3 was prepared by mixing both Grosse-Kunstleve, R.W., Jiang, J.-S., Kuszewski, J., Nilges, N.,
components in a 1:1 molar ratio and concentrating to 8–15 mg/ml Pannu, N.S., et al. (1998). Crystallography & NMR system: a new
for crystallization. Single crystals were obtained by vapor diffusion software suite for macromolecular structure determination. Acta
in hanging drops at room temperature from 10% PEG 3350-8000 Crystallogr. D Biol. Crystallogr. D54, 905–921.
and 50 mM MES (pH 6.0). They appeared after 1–3 days and grew Burmeister, W.P., Gastinel, L.N., Simister, N.E., Blum, M.L., and
to an average size of 0.1  0.1  0.05 mm in 2 weeks. Bjorkman, P.J. (1994). Crystal structure at 2.2 A resolution of the
MHC-related neonatal Fc receptor. Nature 372, 336–343.
Structure Determination CCP4 (Collaborative Computational Project 4) (1994). The CCP4
After a brief soaking in precipitant solutions containing 25% glycerol, suite: programs for protein crystallography. Acta Crystallogr. D 50,
crystals were flash frozen at 100 K. X-ray diffraction data from single 760–763.
crystals were collected using an ADSC Quantum IV CCD detector
Cerwenka, A., Bakker, A.B., McClanahan, T., Wagner, J., Wu, J.,at the X9B beam line of the National Synchrotron Light Source
Phillips, J.H., and Lanier, L.L. (2000). Retinoic acid early inducible(NSLS), Brookhaven National Laboratory and processed with
genes define a ligand family for the activating NKG2D receptor inHKL2000 (Otwinowski and Minor, 1997). The crystals belong to a
mice. Immunity 12, 721–727.space group P43212 with cell dimensions a  b  62.05 and c 
Chapman, T.L., Heikeman, A.P., and Bjorkman, P.J. (1999). The in-237.3 A˚, contain one dimer of NKG2D and one ULBP3 per asymmet-
hibitory receptor LIR-1 uses a common binding interaction to recog-ric unit, and diffract to 2.6 A˚.
nize class I MHC molecules and the viral homolog UL18. ImmunityThe NKG2D homodimer (PDB accession number 1HQ8) was used
11, 603–613.as a model to localize the receptor in the complex by molecular
replecement using AmoRe (Navaza, 1994). The NKG2D phased den- Cosman, D., Mullberg, J., Sutherland, C.L., Chin, W., Armitage, R.,
sity map was insufficient to localize ULBP3. A SeMet MAD dataset Fanslow, W., Kubin, M., and Chalupny, N.J. (2001). ULBPs, novel
was collected from the crystals containing SeMet-ULBP3 at the X9B MHC class I-related molecules, bind to CMV glycoprotein UL16 and
beamline (NSLS). Six selenomethionines were found in the differ- stimulate NK cytotoxicity through the NKG2D receptor. Immunity
ence electron density map with phases from NKG2D using program 14, 123–133.
CNS, version 1.0 (Brunger et al., 1998). After density modification, Das, H., Groh, V., Kuijl, C., Sugita, M., Morita, C.T., Spies, T., and
including solvent flipping, the electron density of ULBP3 was traced Bukowski, J.F. (2001). MICA engagement by human Vgamma2Vdelta2
unambiguously. Model adjustments and rebuilding were done using T cells enhances their antigen-dependent effector function. Immu-
program O (Kleywegt and Jones, 1996). The positional and individual nity 15, 83–93.
B factor refinement was carried out using a maximum likelihood
de Vos, A.M., Ultsch, M., and Kossiakoff, A.A. (1992). Human growthtarget function of CNS v1.0. The refined model consists of residues
hormone and extracellular domain of its receptor: crystal structure94–215 from NKG2D and 9–186 from ULBP3 with one loop of ULBP3,
of the complex. Science 255, 306–312.residues 90–97, missing. A well-defined glutathione molecule forms
Diefenbach, A., Jamieson, A.M., Liu, S.D., Shastri, N., and Raulet,a disulfide bond to Cys 109 of ULBP3. Surface areas were calculated
D.H. (2000). Ligands for the murine NKG2D receptor: expressionwith the program SURFACE of the CCP4 program suite and a probe
by tumor cells and activation of NK cells and macrophages. Nat.radius of 1.4 A˚ (CCP4, 1994). Surface complementarity was calcu-
Immunol. 1, 119–126.lated with the program SC (Lawrence and Colman, 1993). Domain
angles were calculated with the program HINGE (Snyder et al., 1999). Ding, Y.H., Smith, K.J., Garboczi, D.N., Utz, U., Biddison, W.E., and
Wiley, D.C. (1998). Two human T cell receptors bind in a similar
Acknowledgments diagonal mode to the HLA- A2/Tax peptide complex using different
TCR amino acids. Immunity 8, 403–411.
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